Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pulmonary Aspergillosis in Tuberculosis Patients
Sponsor: Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Summary
Pulmonary tuberculosis (PTB) is the most common cause of lung destruction, contributing to coinfections development, and Aspergillosis spp. is one of the most important. Diagnosis of chronic pulmonary aspergillosis (CPA) in PTB patients is difficult due to similarity of clinical and radiological data, especially in resource-constrained settings. Differentiation of PTB patients with singling out a group with a higher Aspergillus IgG level during the initial examination will help physicians to orient to further examination of CPA. Objectives: to determine the prevalence of aspergillosis in Koch's bacillus-positive and Koch's bacillus-negative PTB patients and antifungal resistance of Aspergillus species isolates in Central Asia countries.
Official title: Prevalence of Chronic Pulmonary Aspergillosis and Antifungal Drug Resistance of Aspergillus Spp. in Pulmonary Tuberculosis Patients in Uzbekistan
Key Details
Gender
All
Age Range
19 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2020-01-01
Completion Date
2030-12-31
Last Updated
2025-04-04
Healthy Volunteers
No
Conditions
Interventions
Aspergillus IgG detection
Aspergillus IgG will be detected among pulmonary tuberculosis patients. 5 ml of vein blood will be collected for ELISA.
Locations (1)
Research institute of epidemiology, microbiology and infectious diseases
Tashkent, Uchtepa, Uzbekistan